Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16INK4a can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer. Overlapping reading frames in the INK4A/ARF gene encode p16INK4a and a distinct tumour-suppressor protein, p19ARF (ref. 3). Here we describe the generation and characterization of a p16Ink4a-specific knockout mouse that retains normal p19Arf function. Mice lacking p16Ink4a were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16Ink4a exhibited enhanced mitogenic responsiveness, consistent with the established role of p16Ink4a in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19Arf (ref. 4), p16Ink4a-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16Ink4a-null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19Arf or p53 (refs 4, 5). Furthermore, p16Ink4a deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16Ink4a, along with p19Arf, functions as a tumour suppressor in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p19 Arf and, to a lesser extent, p16 Ink4a have been shown to play a role in the activation of cellular senescence and immortalization on passaging of primary mouse cells in culture (26, 43, 44).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [43]
In the citing paper
“In vivo (mouse model) studies indicate that p16 suppresses the development of spontaneous cancer (Sharpless et al., 2001).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Sharpless et al., 2001
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Real-time methylation-specific PCR (MSR) was used to detect the methylation of CpG islands flanking the translation start site of murine p16Ink4a 28,29, revealing a significant increase in methylated CpG sites at the promoter region of p16Ink4a in middle-aged mouse tissues after TAC treatment compared with vehicle controls (Figure 3H).”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [28]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“exhibit more rapid growth rates and are more readily immortalized in culture, are susceptible to transformation by activated H-Ras alone, and exhibit resistance to Ras-induced senescenc”
BackgroundRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice heterozygous for this mutant allele were crossed with EIIa-Cre mic”
MethodD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 1×
“Accumulation of p16 INK4a correlates with the onset of senescence in human cell”
Background
Cited by
Items 801–850 of 850
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600792
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600798
González-Meljem, J. M., Haston, S., Gallage, S., Innes, A. J., & Scheckhuber, C. Q. (2024) · Springer eBooks · doi:10.1007/978-3-031-76469-1_2
Role of Cyclin-Dependent Kinase Inhibitors (CKIs) as a Prognostic Biomarker for Cancer
Hossain, M. G., & Kabir, Y. (2025) · Springer eBooks · doi:10.1007/978-3-032-00763-6_142 · Cited by 1
Senescence in Oncogenesis: From Molecular Mechanisms to Therapeutic Opportunities
Muñoz-Galván, S., & Carnero, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_7
Regulation of G1/S Cell Cycle Progression by Transforming Growth Factor-beta
Zhang, F. (2003) · Helda - University of Helsinki Institutional Repository
Nilsson, L. M. (2007) · DiVA at Umeå University (Umeå University)
Additional file 5 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627175
Additional file 1 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627163
Additional file 2 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627166
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600780
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600768
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600783
Additional file 7 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627181
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600786
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600777
Additional file 6 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627178
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600789
Additional file 4 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627172
Additional file 3 of PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13627169
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600774
Sun, L., Liu, Z., Ning, K., Wu, Z., Chen, Z., Wu, Z., & Yin, X. (2023) · Figshare · doi:10.6084/m9.figshare.22600771
Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortalityPreprint
Yamada, L., Liu, H., von Muhlinen, N., Harris, C. C., & Horikawa, I. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697195
Stephan, P., Plassard, D., Keyes, W. M., & Hérault, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06079-3
Cudejko, C. (2010) · theses.fr (ABES) · doi:10.70675/3be56540zf3b1z4ee1z99ffz2dbbe7a0dc17
Roles of the multifunctional protein E4F1 in cellular senescence
Maciejewska, Z. (2010) · theses.fr (ABES) · doi:10.70675/21f99f8bze775z413fza364z48dd293ca460
p16INK4a, régulation du cycle cellulaire et microARN
Chien, W. W. (2009) · theses.fr (ABES) · doi:10.70675/dbb5386dzc679z454fzad91z9d53a61231ff
Rôle de la protéine multifonctionnelle E4F1 et de la voie p53 dans l’homéostasie cutanées
Goguet-Rubio, P. (2013) · theses.fr (ABES) · doi:10.70675/cf006e65z80d3z43f4za521z25580e174bc9
Vanin-1 et la réponse mésenchymateuse à un stress inflammatoire ou tumoral
Giessner, C. (2015) · theses.fr (ABES) · doi:10.70675/ad91f126zab69z4befzb47bz6ebe23e41f19
Insights into Atoh1 Phosphorylation in Cerebellum Development and Medulloblastoma Formation
Bihannic, L. (2015) · theses.fr (ABES) · doi:10.70675/86a1a942zc5d2z4385z8b8eze83cb52cac71
Ferdousi, L. V. (2014) · theses.fr (ABES) · doi:10.70675/9d73199ez7949z4602zadcfz6763e4bdd1b0
Cintas, C. (2017) · theses.fr (ABES) · doi:10.70675/d19569d2z4eaez4a9azae8bz1e155d6b15b3
The role of the transcription factor BRN2 in melanomagenesis
Michael, H. A. M. M. (2018) · theses.fr (ABES) · doi:10.70675/26b92b06z2271z43b7za83bz0ea93177e5a6
Generation of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Caractérisation de la sénescence des cardiomyocytes et identification de marqueurs associés
Maggiorani, D. (2017) · theses.fr (ABES) · doi:10.70675/a58747bczd60bz4482za3b2z7ae33d26ffa4 · Cited by 1
L’échappement à la sénescence induite par chimiothérapie : Un nouveau rôle de la protéine AGR2
Maarouf, A. (2021) · theses.fr (ABES) · doi:10.70675/2804fda4z0d12z4a01za7eezd95a7d0b70d2
How Somatic Mutations cause Aging without Causing AgingPreprint
Wolf, A. M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6431458
Senolytic drug discovery and mechanisms of action in BRAF-V600E oncogene-induced senescence
L’Hôte, V. (2022) · theses.fr (ABES) · doi:10.70675/acd5f426zc1b2z446fz8404z0f8f121081f8 · Cited by 1
Mazeyrie, L. (2024) · theses.fr (ABES) · doi:10.70675/04dabd62z8f26z4393zac25z0070faaa4fb9
Rodriguez-Rosario, A. E., Rangel, R., Balbin, N., Nizami, Z. N., Hadi, J. A., Noor, A. T., Dong, L., Corona, A., Bhavani, N., Cruz-Sánchez, R. M., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013976
Liu, K.-W. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
The Senescent Cell Induced Bystander Effect
Wordsworth, J. (2014)
RB/E2F Regulation and Dual Activity in the Melanocytic System
Halaban, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_13
Knights, C. D., & Pestell, R. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_1
(2003) · PubMed · Cited by 146
Metadata
- Authors
- Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6851
- Pages
- 86-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2017235640
- Cited by
- 848
- References
- 30
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 19 · 2023: 26 · 2022: 15 · 2021: 36 · 2020: 17 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 17 · 2015: 29 · 2014: 32 · 2013: 34 · 2012: 34
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p16INK4a, p19ARF, tumour suppressor, senescence, carcinogenesis, knockout mice, thymic hyperplasia, T cell proliferation, Ras-induced senescence, cell immortalization, carcinogen-induced cancer, p53
- MeSH terms
- Animals, Carcinogens, Cell Division, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Male, Neoplasms, Proteins, T-Lymphocytes, Thymus Gland, Urethane, 9,10-Dimethyl-1,2-benzanthracene, Gene Deletion, Mice, Knockout, Gene Targeting, Genes, p16, Genetic Predisposition to Disease, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.